Faculty of Chemistry University of Warsaw

H. F. DeLuca, I. K. Sibilska, R. R. Siciński, L. A. Plum. Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds. WO 2017 23617A1 (9 Febr 2017)

​

H. F. DeLuca, L. A. Plum, I. Sibilska, R. R. Siciński. 2-Methylene-vitamin D analogs and their uses. WO 2013 59060A1 (25 Apr 2013). 

 

H. F. DeLuca, L. A. Plum, I. Sibilska, R. R. Siciński. 2-Methylene-vitamin D analogs and their uses. WO 2013 59021A1 (25 Apr 2013). 2-methylene  WO 2013 59060A1

 

H. F. DeLuca, M. Clagett-Dame, L. A. Plum, A. Głębocka, R. R. Siciński. 2-Methylene-19,23,24-trinor-1α-hydroxyvitamin D3. WO 2013 32,846A1 (07 Mar 2013). 

 

H. F. DeLuca, M. Clagett-Dame, L. A. Plum, R. R. Siciński, A. Głębocka. 2-Methylene-20(21)-dehydro-19,24,25,26,27-pentanor-vitamin D analogs. WO 2013 12,644A1 (24 Jan 2013). 

 

H. F. DeLuca, L. A. Plum, R. R. Siciński, I. Sibilska, M. Clagett-Dame. 3-Desoxy-2-methylene-19-nor-vitamin D analogs and their uses. WO 2012 174095A1 (20 Dec 2012).

 

H. F. DeLuca, I. Sibilska, K. M. Barycka, R. R. Siciński, K. Płońska-Ocypa, R. Barycki, L. A. Plum, M. Clagett-Dame. 1-Desoxy-2-methylene-19-nor-vitamin D analogs and their uses. WO 2011 41,590A3 (30 Jun 2011).

 

H. F. DeLuca, A. Głębocka, L. A. Plum, M. Clagett-Dame, R. R. Siciński,  19-Nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring. WO 2011 41,596A2 (07 Apr 2011). 

 

H. F. DeLuca, L. A. Plum, M. Clagett-Dame, K. Sokołowska, A. Mouri?o, , R. R. Siciński. 6-Methylvitamin D3 analogs and their uses. WO 2011 41,599A2 (07 Apr 2011).

 

H. F. DeLuca, A. Głębocka, K. Sokołowska, R. R. Siciński, L. A. Plum, M. Clagett-Dame. 19-Nor-vitamin D analogs with 1,2-dihydrofuran ring. WO 2010 6,123A2 (14 Jan 2010). 

 

H. F. DeLuca, A. Głębocka, K. Sokołowska, R. R. Siciński, L. A. Plum, M. Clagett-Dame. 19-Nor-vitamin D analogs with 3,2-dihydrofuran ring. WO 2010 6,121A2 (14 Jan 2010). 

 

H. F. DeLuca, M. Clagett-Dame, L. A. Plum, R. R. Siciński, K. Plońska-Ocypa, N. J Nieves. 13,13-Dimethyl-des-C,D analogs of 1 ,25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions. WO 2009 94,4260A1 (30 Jul 2009).

 

H. F. DeLuca, M. Clagett-Dame, L. A. Plum, A. Głębocka, R. R. Siciński. 2-Methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs. WO 2009 86,440A1 (09 Jul 2009)

 

H. F. DeLuca, R. R. Siciński, A. Głębocka, L. A. Plum, M. Clagett-Dame. 19-Nor-vitamin D analogs with 1,2, or 3,2 heterocyclic ring. WO 2008 26,078A2 (06 Mar 2008). 

 

H. F. DeLuca, A. Głębocka, R. R. Siciński, L. A. Plum, M. Clagett-Dame. 1α-Hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain. WO 2008 23,278A2 (28 Feb 2008).

 

H. F. DeLuca, R. R. Siciński, L. A. Plum, M. Clagett-Dame, A. Glebocka. 1α-Hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and use thereof. WO 2007 117,563A2 (18 Oct 2007). 

 

H. F. DeLuca, K. Plońska-Ocypa, R. R. Siciński, P. Grzywacz, L. A. Plum, M. Clagett-Dame. Des-C,D analogs of 1α,25-hydroxy-19-norvitamin D3. WO 2007 28,000A2 (08 Mar 2007). 

 

H. F. DeLuca, R. R. Siciński, L. A. Plum, M. Clagett-Dame, S. Gowlugari. 2α-Methyl-19-nor-1α-hydroxy-homopregnacalciferol and its uses. WO 2006 57,902A2 (01 Jun 2006). 

 

 H. F. DeLuca, R. R. Siciński, L. A. Plum, M. Clagett-Dame. 2 -Methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses. WO 2006 057899A2 (01 Jun 2006). 

 

H. F. DeLuca, R. Barycki, P. K. Grzywacz, L. A. Plum, R. R. Siciński. 2-Alkylidene-18,19-dinor-vitamin D compounds. WO 2005 102995A1 (03 Nov 2005). 

 

H. F. DeLuca, R. R. Siciński, S. Gowlugari. 2-Methylene-19-nor-vitamin D2 compounds. WO 2005 18,658A1 (03 Mar 2005). 

 

H. F. DeLuca, R. R. Siciński, P. K. Grzywacz. (20S)-1α-Hydroxy-2-methylene-19-nor-vitamin D3 and its uses. WO 2005 18,648A1 (03 Mar 2005). 

 

H. F. DeLuca, R. R. Siciński, A. Głębocka, L. A. Plum. 2-Propylidene-19-nor-vitamin D compounds. WO 2004 92,118A2 (28 Oct 2004). 

 

H. F. DeLuca, R. R. Siciński, P. K. Grzywacz. (20S)-1α-Hydroxy-2α-methyl and 2α-methyl-19-nor-vitamin D3 and their uses. WO 2003 88,977A1 (30 Oct 2003). 

 

H. F. DeLuca, S. Gowlugari, R. R. Siciński. Method of synthesizing 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol. WO 2003 84,925A1 (16 Oct 2003). 

 

H. F. DeLuca, P. K. Grzywacz, R. R. Siciński. Synthesis of indole thiazole compounds as ligands for the AH receptor. WO 2003 68,742A1 (21 Aug 2003). 

 

H. F. DeLuca, J. Song, M. Clagett-Dame, R. E. Peterson, W. M. Westler, R. R. Siciński. Preparations and use of an AH receptor ligand, 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester. WO 2002 64,138A1 (22 Aug 2002). 

 

H. F. DeLuca, R. R. Siciński, S. Gowlugari, L. A. Plum, M. Clagett-Dame. 1α-Hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications. WO 2002 20,021A1 (14 Mar 2002). 

 

H. F. DeLuca, R. R. Siciński. 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds. WO 2001 92,221A1 (6 Dec 2001). 

 

H. F. DeLuca, R. R. Siciński. 2-Alkylidene-19-nor-vitamin D compounds and their therapeutic uses. WO 01 74,766A1 (11 Oct 2001). 

 

H. F. DeLuca, R. R. Siciński. 26,27-Homologated-20-epi-2-alkyl-19-nor-vitamin D compounds. WO 2001 74,765A1 (11 Oct 2001). 

 

H. F. DeLuca, R. R. Siciński, H. Holden, J. B. Thoden. Crystalline 1α,24(S)-dihydroxyvitamin D2 and method of purification thereof. WO 2001 02,352A1 (11 Jan 2001). 

 

H. F. DeLuca, R. R. Siciński, H. Holden, J. B. Thoden. Crystalline 1α-hydroxyvitamin D2 and method of purification thereof. WO 2000 43,361A1 (27 Jul 2000). 

 

H. F. DeLuca, R. R. Siciński. Method of locking 1α-OH of vitamin D compounds in axial orientation. WO 1999 59,966A1 (25 Nov 1999). 

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, X. Jia. All-trans-retinol metabolite. WO 1999 12,922A1 (18 March 1999). 

 

H. F. DeLuca, R. R. Siciński. 2-Alkylidene-19-nor-vitamin D compounds. WO 1998 41,501A1 (24 Sept 1998). 

 

H. F. DeLuca, R. R. Siciński. 2-Alkyl-19-nor-vitamin D compounds. WO 1998 41,500A1 (24 Sept 1998).

 

H. F. DeLuca, R. R. Siciński, K. L. Perlman. 18-Nor-vitamin D compounds. WO 1996 16,036A1 (30 May 1996).

 

H. F. DeLuca, R. R. Siciński, K. L. Perlman. 18,19-Dinor-vitamin D compounds. WO 1996 16,035A1 (30 May 1996).

 

H. F. DeLuca, R. R. Siciński. (E)-20(22)-Dehydrovitamin D compounds. WO 1995 12,575A1 (11 May 1995). 

 

H. F. DeLuca, H. K. Schnoes, K. L. Perlman, R. R. Siciński, J. M. Prahl. 19-Nor-vitamin D compounds. WO 1990 10,620A1 (20 Sept 1990).

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, Y. Tanaka. 1α-Hydroxyvitamin D2 analogs and process for preparing same. WO 1985 03,939A1 (12 Sept 1985).

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, Y. Tanaka. 1α,25-Dihydroxy-22Z-dehydrovitamin D compound. WO 1985 03,300A1 (01 Aug 1985).

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, Y. Tanaka. Side-chain unsaturated 1α-hydroxyvitamin D compounds. WO 1985 03,299A1 (01 Aug 1985).

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, Y. Tanaka. Hydroxyvitamin D2 isomers. WO 1985 03,298A1 (01 Aug 1985).

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, Y. Tanaka. 1α,25-Dihydroxyvitamin D2 compounds and methods for their preparation. WO 1985 02,189A1 (23 May 1985).

 

H. F. DeLuca, H. K. Schnoes, R. R. Siciński, Y. Tanaka. Process for the preparation of 1α-alpha,25-dihydroxylated vitamin D2 and related compounds. WO 1984 04,527A1 (22 Nov 1984).